Research at Roswell Park Comprehensive Cancer Center shows that putting a three-day limit on opioid prescriptions to treat surgical pain after hospital discharge reduces the number of patients who become chronic opioid users without compromising pain relief or recovery. It also reduces the amount of opioids circulating in the community — a grave concern, given that opioids are implicated in 130 overdose deaths in the U.S. every day.

The medical team at Roswell Park Comprehensive Cancer Center is celebrating a big honor as the year comes to a close with the release of Buffalo Spree magazine’s Top Doctors 2023. This year’s list includes 142 physicians across 32 specialties, which is compiled thorough peer surveys of Western New York doctors.

A brain cancer vaccine developed at Roswell Park Comprehensive Cancer Center appears to be safe and significantly extends survival in newly diagnosed glioblastoma patients, according to a Phase 2A single-arm clinical trial. The study, “Phase 2A Study of SurVaxM Plus Adjuvant Temozolomide for Newly Diagnosed Glioblastoma,” appears this week in the Journal of Clinical Oncology. Manmeet Ahluwalia, MD, MBA, Fernandez Family Foundation Endowed Chair in Cancer Research, Chief of Medical Oncology, Deputy Director and Chief Scientific Officer of Miami Cancer Institute, served as overall Principal Investigator.